Clinical Trial Update: Remission of Type 2 Diabetes With Dapagliflozin (READ Trial) [Phase 4]

View source ↗

Summary

Phase 4 READ trial evaluated whether dapagliflozin could induce remission in people with Type 2 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED